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Development of an Animal Fracture Model
for Evaluation of Cement Augmentation Femoroplasty:
An In Vitro Biomechanical Study
Qiang Luo,1 William W. Lu,1 Tak-Wing Lau,1 and Frankie Leung1,2
Abstract
Osteoporotic hip fracture is the most severe kind of fracture with high morbidity and mortality. Patients’ ambu-
lation and quality of life are significantly affected by the fracture because only 50% regain their prefracture func-
tional status, even if they undergo surgeries. There are many issues associated with the current preventive
methods e.g., cost, side effects, patient compliance, and time for onset of action. Femoroplasty, the injection
of bone cement into the proximal femur to augment femoral strength and to prevent fracture, has been an option
with great potential. However, until now femoroplasty has remained at the stage of biomechanical testing. No
in vivo study has evaluated its safety and effectiveness; there is not even an animal model for such investigations.
The objective of this study was to develop a proximal femur fracture goat model that consistently fractures at the
proximal femur when subject to vertical load, simulating osteoporotic hip fractures in human. Six pairs of fresh
frozen mature Chinese goats’ femora were obtained and randomly assigned into two groups. For the experimen-
tal group, a cylindrical bone defect was created at the proximal femur, while the control was left untreated. In
addition, a configuration to mimic the mechanical axis of the goat femur was developed. When subjected to
load along the mechanical axis, all the specimens from the bone defect group experienced femoral neck fractures,
while fractures occurred at the femoral neck or other sites of the proximal femur in the control group. The bio-
mechanical property (failure load) of the bone defect specimens was significantly lower than that of the control
specimens ( p< 0.05). Osteoporotic hip fractures of humans were simulated by a goat fracture model, which may
serve as a reference for future femoroplasty studies in vivo. The newly developed configuration simulating a fem-
oral mechanical axis for biomechanical tests was practicable during the study.
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Introduction
Osteoporotic hip fracture is the most severe kind offracture caused by osteoporosis. Hip fracture patients
have a high mortality rate of up to 30% during the first
year after fracture.1 In addition, their ambulation and quality
of life are significantly affected by the fracture, and only 50%
regain their prefracture functional status.2 This constitutes a
significant health problem and a major burden to society.
Hence in the past few decades, there have been numerous at-
tempts to improve the management of these fractures, both
through surgical treatment and preventive measures.
The currently available methods of prevention include
noninvasive physical protection and various pharmacologi-
cal agents. Padded hip protectors and energy-absorbing mat-
tresses have been shown to have limited effectiveness in
reducing hip fractures.3–5 An array of drugs, including cal-
cium, vitamin D, bisphosphonates, and strontium ranelate,
have been used to improve bone mineral density, thus de-
crease the risk of fractures. However, there are many issues
associated with the use of these methods (e.g., cost, side ef-
fects, patient compliance, and time for onset of action) that
can inhibit efficacy.6–8 A logical solution is the develop-
ment of a prophylactic surgical intervention to increase the
strength of the proximal femur and to decrease the risk of
fracture. This technique should be quick, easy, and minimally
invasive and carry minimal risk to the patients. Femoroplasty,
the injection of bone cement into the proximal femur to aug-
ment the femur and to prevent fracture, has been an option
with great potential.
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Prophylactic bone cement augmentation of proximal fe-
mur remains at the stage of biomechanical testing. There
have only been some in vitro studies in cadaveric bone,
which showed beneficial effect of femoroplasty in rein-
forcing bone strength.9–13 However, there has not been
enough evidence to support its clinical feasibility and
benefits. Moreover, its acceptance in clinical application
is still hampered by possible adverse effects, which in-
clude exothermic reaction during bone cement harden-
ing, the effect on blood supply of bone and adjacent soft
tissues, the increase in intramedullary pressure, and the
risk of fat embolism.10–12 Therefore, before femoroplasty
can become a viable clinical option, these potential adverse
effects must be investigated with appropriate in vivo studies
to evaluate the safety issues and therapeutic potential of
femoroplasty.
The purpose of this study was to develop an animal model
for femoroplasty in vivo study. The model can consistently
fracture at the proximal femur when subject to load, simulat-
ing osteoporotic hip fractures in human. We hypothesize that
with a bone defect in the proximal femur, this femur fracture
model will serve this purpose well.
Methods and Materials
Six pairs of fresh frozen Chinese mountain goat femurs
were utilized in this study. Any focal bone pathology was
precluded by using radiographs in two planes. The speci-
mens were divided into two groups. The left femur from
each pair served as the bone defect group, and the right
femur was left untreated and served as the control.
For the bone defect group, a cylindrical bone defect was
created through the lateral wall of the proximal femur to
the femoral head. Afterward all specimens were subjected
to biomechanical tests using the Material Testing System
(MTS 858 Mini Bionix, Minneapolis, MN) with a newly
created configuration. Based on the concept of the human
mechanical axis of the lower extremity, the goat femoral
mechanical axis was defined as the line from the center of
femoral head to the center of knee. The vertical load was
applied through the femoral mechanical axis until fractures
occurred.
Creating a bone defect
First each femur from bone defect group was fixed on the ex-
periment table, simulating the position of human surgery. The
entry point was defined by the line passing through the greater
trochanter along the long axis of the bone at the level of lesser
trochanter. A hole was made at this point with a 5-mm-diameter
bone drill. A 4-cm-long cylindrical cancellous bone defect at an
angle of 45 to the longitudinal axis of the femur was then made
with a 5-mm-diameter burr, reaching the dense cancellous bone
in the femoral head (Fig. 1).
Biomechanical testing
All femora were stored in sealed plastic bags at 20C
after the development of bone defect until 1 day before bio-
mechanical testing, at which time they were removed from
the freezer and allowed to thaw overnight to room tempera-
ture in the same sealed plastic bags.
Biomechanical tests were performed in a configuration that
simulated the mechanical axis of the goat femur (Fig. 2). The
distal femur of the specimen was embedded into a cylindrical
tray with Huntsman glue mixture (Araldite AW2104+
Hardener HW2934, Huntsman, Switzerland). The femoral
shaft was oriented so that the center of femoral head and the
center of the knee joint were located in the same vertical
line, which represented the biomechanical axis for load testing.
The specimens were left wrapped in gauze soaked in saline so-
lution for 24 h to ensure glue fixation of the distal end of femur.
The whole construct was placed in a servo hydraulic grip con-
trol testing machine (MTS 858 Mini Bionix) under a custom-
made stainless steel spherical pressing shell. The femoral head
was preloaded to 40 N through the pressing shell attached to
the actuator of MTS. The actuator was displaced downward
at a rate of 1 mm/s until failure occurred (Fig. 3). The fracture
position and fracture load were recorded.
Statistical analysis
Significant differences, defined by p < 0.05, in the vari-
ables of interest (fracture load, yield load) between the
bone defect group and the control group using paired t-
tests. All statistical calculations were performed with SPSS
version 15 software (SPSS Inc., Chicago, IL).
FIG. 1. (A) The entry point
was defined by the line pass-
ing through the greater tro-
chanter along the long axis of
the bone at the level of lesser
trochanter. A cylindrical
cancellous bone defect,
4.0 cm long at an angle of 45
to the longitudinal axis of the
femur, was then made with a
5-mm-diameter burr, reach-
ing the dense cancellous bone
in the femoral head. (B) The
bone defect under X-ray.
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Results
All six specimens from the bone defect group fractured at
the femoral neck (Fig. 3), while fractures occurred at the
femoral neck or other sites of proximal femur in the control
group.
For biomechanical properties, the average failure load in
the control group was 3635– 820 N while 2348– 944 N in
the bone defect group. The difference regarding yield and
failure load between the two groups was significant ( p =
0.030 and p = 0.02, respectively; Fig. 4).
Discussion
Osteoporotic hip fracture is a great challenge to most or-
thopedic surgeons, and the complication rates after surgery
are high. The most effective methods may be preventive pro-
cedures. However, the currently available preventive meth-
ods, including noninvasive physical protection and various
pharmacological agents, are far from ideal and hindered by
adverse effects, patients’ compliance, or onset time of action.
Hence in the past few decades, doctors have attempted to de-
velop a prophylactic surgical procedure to protect the osteo-
porotic hip.
In 2004, Heini et al.12 first reported that femoroplasty,
bone cement (polymethylmethacrylate [PMMA]) augmenta-
tion of the proximal femur, could reinforce the proximal
femur and potentially decrease the risk of hip fracture. Sub-
sequent biomechanical studies further proved that femoro-
plasty using different bone cements (including PMMA and
other bioactive cements) and different augmentation pat-
terns could improve femoral biomechanical properties,
decreasing the risk of osteoporotic hip fracture. The side
effects related to this surgical procedure were presented
and roughly addressed using cadaveric osteoporotic bone.
However, until now the safety and feasibility issues had
not been addressed in vivo; a specific animal model for fem-
oroplasty in vivo study did not even exist. To our knowledge,
the goat is a well-established animal model to study femoral
FIG. 2. (A) Mechanical
axis under X-ray. (B) Setup
for mechanical testing: the
center of the femoral head
and the midpoint between
femoral entepicondyle and
the lateral epicondyle were
located in the same vertical
line.
FIG. 3. After biomechanical
testing, the fractures occurred (A) at
the femoral neck in bone defect
group and (B) at the femoral head in
the control group.
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head osteonecrosis.14,15 So we developed the proximal femur
fracture goat model to simulate human osteoporotic hip frac-
ture for future in vitro and in vivo studies of femoroplasty.
Through creating a cylindrical bone defect in the goat
proximal femur, we simulated a fracture. Due to this weak
point between the femoral neck and calcar, the bone defect
specimens experienced femoral neck fracture. This result
was consistent with our original hypothesis. In addition,
the fracture load and yield load in the control group were
1.5 and 2.2 times higher, respectively, than in the bone defect
group (Fig. 5).
In this study, we aimed to develop an animal model to
mimic human hip fracture. The results showed that the
goat model consistently fractured at femoral necks when sub-
jected to vertical load, and the fracture line was similar to os-
teoporotic femoral neck fracture that occurs in humans. In
addition, the mechanical axis of the goat femur was tested
biomechanically, and the newly developed configuration
was practicable during this study.
There are some limitations in this study. First, human os-
teoporotic hip fracture can hardly be duplicated on a large
four-legged animal. Most osteoporotic hip fractures happen
when individuals sustain low-energy trauma falling from
standing height. Goats have little chance of falling on the
great trochanter. Second, most human hip fractures are inter-
trochanteric fractures. Possibly because the goat femur is
much shorter than the human femur, this model’s fracture lo-
cation was at the femoral neck rather than the intertrochan-
teric region. Third, the configuration of falling on the
greater trochanter is widely accepted as a test of the biome-
chanical properties of the femur; however, when it is applied
to a goat femur, we found that fracture location was different.
So, the configuration of one leg stance was selected. In addi-
tion, because osteoporotic goat bone can hardly be obtained,
the goat femora used in this study were healthy.
In conclusion, the aim of establishing this goat femoral
fracture model was to evaluate the safety and feasibility of
femoroplasty. The limitations of this model will not matter
too much for further in vivo study of femoroplasty.
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